Sol-Gel Technologies (SLGL) Short-term Investments (2016 - 2025)
Sol-Gel Technologies' (SLGL) quarterly Short-term Investments came in at $13.0 million in Q4 2025, up 107950.0% year-on-year from N/an in Q4 2024, and up 107950.0% on a QoQ basis from $12000.0 in Q3 2025.
Sol-Gel Technologies (SLGL) Short-term Investments (2016 - 2025) Analysis & Trends
Sol-Gel Technologies (SLGL) has 10 years of Short-term Investments data on file, last reported at $13.0 million in Q4 2025.
- On a quarterly basis, Short-term Investments rose 107950.0% year-over-year to $13.0 million in Q4 2025; TTM through Dec 2025 was $13.0 million, a 107950.0% increase from a year earlier, with the FY2025 full-year figure at $13.0 million, up 107950.0% from the prior year.
- Short-term Investments for Q4 2025 stood at $13.0 million, up from $12000.0 in the prior quarter.
- Over the last five years, Short-term Investments for SLGL reached as high as $21.6 million in Q1 2021 and fell as low as $12000.0 in Q4 2024.
- Historically, Short-term Investments has averaged $9.8 million across 5 years, with a median of $8.8 million in 2022.
- Across the five-year window, Short-term Investments sank 99.94% in 2024 and soared 107950.0% in 2025, its largest moves.
- Year by year, Short-term Investments stood at $1.7 million in 2021, then jumped by 407.78% to $8.7 million in 2022, then surged by 135.9% to $20.5 million in 2023, then sank by 99.94% to $12000.0 in 2024, then surged by 107950.0% to $13.0 million in 2025.
- Per Business Quant data, the three most recent Short-term Investments figures were $13.0 million in Q4 2025, $12000.0 in Q3 2025, and $12000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.97 Mn |
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Jun 30, 2024 | 4.01 Mn |
| Mar 31, 2024 | 5.01 Mn |
| Dec 31, 2023 | 20.47 Mn |
| Sep 30, 2023 | 12.00 Mn |
| Jun 30, 2023 | 13.50 Mn |
| Mar 31, 2023 | 8.50 Mn |
| Dec 31, 2022 | 8.68 Mn |
| Sep 30, 2022 | 17.00 Mn |
| Jun 30, 2022 | 21.00 Mn |
| Mar 31, 2022 | 9.00 Mn |
| Dec 31, 2021 | 1.71 Mn |
| Jun 30, 2021 | 20.90 Mn |
| Mar 31, 2021 | 21.60 Mn |
| Dec 31, 2020 | 21.65 Mn |
| Dec 31, 2019 | 40.97 Mn |